CRTH2 antagonists in the treatment of allergic responses involving TH2 cells, basophils, and eosinophils
Annals of Allergy, Asthma & Immunology
December 2012 Volume 109, Issue 6, Pages 365-374 CME Review
Participants will be able to demonstrate increased knowledge of the clinical treatment of allergy/asthma/immunology and how new information can be applied to their own practices
Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for ContinuingMedical Education (ACCME) to provide continuing medical education for physicians.
Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Robert G. Townley, MD (Senior Author)
Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief)
Physicians involved in providing patient care in the field of allergy/asthma/immunology
At the conclusion of this activity, participants should be able to:
● Discuss the importance of CRTH2 in the cells of the immune system and its role in allergic inflammation
● Describe the role of PGD2 and its receptors as well as its role after it is released from the mast cell
Robert G. Townley, MD and Swati Agrawal, MBBS
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance